BACK

GHM's Strategic Partner Debuts Innovations at ISSCR 2025

2025-06-12 Visitors:

The 2025 Annual Meeting of the International Society for Stem Cell Research (ISSCR) holdingin Hong Kong from June 11 to 14, 2025.

8498570e04803f3fe096091d3294016.png

Founded in 2002, ISSCR is a nonprofit, multinational, and interdisciplinary scientific organisation dedicated to stem cell research. The ISSCR Annual Meeting is the world's largest international gathering for stem cell research and regenerative medicine, expected to attract over 4,000 professionals globally to share breakthroughs and advancements in the field.

4bb63eb6ba6160458610228e0999801.png

Global Health Management’s Strategic Partner: Qingdao Raisecare at the Exhibition


Qingdao Raisecare Biotechnology Co., Ltd. (Booth: 3BE-2007), a strategic partner of Global Health Management Co., Ltd., showcased cutting-edge equipment, including the latest flow cytometers, sample pre-processing instruments, and automated microscopic scanning imaging systems.The exhibition highlights Raisecare’s leading technological capabilities in flow cytometry diagnostics.


Exhibition Instrument Highlights


機1.png

Automatic Microscanner RCABM-5 


9b3233f76dd5e249e368f45f71118b2.jpg

Flow Cytometer 3L13C 


機3.jpg

 RaiseCyte Sampler


(For detailed specifications, visit Booth 3BE-2007 for in-person discussions,Or follow our wechat official account GlobalHealth_HK to contact us and leave a message.)


Global Health Management Empowers Strategic Deployment in Hong Kong, Macau, and Taiwan Region


Leveraging Raisecare's technological expertise and Global Health Management's channel resources, the two parties will collaboratively advance the following strategies:

1. Hong Kong, Macau & Taiwan region Bridgehead Initiative


Global Health Management will utilise its cross-border healthcare resource integration capabilities to support Raisecare's expansion into international markets. This initiative leverages Hong Kong as a strategic gateway for global deployment, enabling technology transfer and synergistic channel development across regions.


2. Global Ecosystem Development


The partnership will accelerate Raisecare's transition from an equipment supplier to a global integrated solutions provider, facilitating alignment with international technical standards. The successful entry into the Hong Kong market marks a critical step in elevating Raisecare’s flow cytometry technology from domestic leadership in China to global competitiveness.


Through trilateral synergy of "Technology + Channels + Services", the collaboration aims to:Establish new benchmarks in the Asia-Pacific precision medicine market. Lay the foundation for future expansion into Southeast Asia, Europe, and North America.



2025.6.11

 

Global Health 主LOGO(1).png